This post was originally published on this site
https://i-invdn-com.investing.com/trkd-images/LYNXMPEI8D079_L.jpg
Moderna filed suit against BioNTech and its partner Pfizer Inc (NYSE:PFE) last month for patent infringement in the development of the first COVID-19 vaccine approved in the United States.
Bancel, speaking in Tokyo, said Moderna is considering building facilities in Japan to produce mRNA-derived products.
